-174G>C interleukin-6 gene polymorphism in Tunisian patients with coronary artery disease

Annals of Saudi Medicine

Volumn 31, Issue 1, 2011, Pages 40-44

  Ghazouani, Lakhdar ^a   Abboud, Nesrine ^a   Khalifa, Sonia Ben Hadj ^a   Added, Faouzi ^b   Khalfallah, Ali Ben ^c   Nsiri, Brahim ^a   Mediouni, Mounira ^d   Mahjoub, Touhami ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^c Hopital Menzel Bourguiba   (Tunisia)

^d Hospital Center of Jendoubad   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DNA POLYMORPHISM; EUROPE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SMOKING; TUNISIA;

AGED; ALLELES; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-6; LOGISTIC MODELS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; TUNISIA;

EID: 79251614033     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.4103/0256-4947.75777     Document Type: Article

References (29)

1. Napoleão P, Santos MC, Selas M, Viegas-Crespo AM, Pinheiro T, Ferreira RC. Variations in inflammatory markers in acute myocardial infarction: A longitudinal study. Rev Port Cardiol 2007;26:1357-63.
2. Ross R. Atherosclerosis an inflammatory disease. N Engl J Med 1999;340:115-26.
3. Shishehbor MH, Bhatt DL. Inflammation and atherosclerosis. Curr Atheroscler Rep 2004;6:131-9.
4. Alexander RW. Inflammation and coronary artery disease. N Engl J Med 1994;331:468-9.
5. Dienz O, Rincon M. The effects of IL-6 on CD4 T cell responses. Clin Immunol 2009;130:27-33.
6. Monaco C, Andreakos E, Kiriakidis S, Feldmann M, Paleolog E. T-cell-mediated signalling in immune, inflammatory and angiogenic processes: The cascade of events leading to inflammatory diseases. Curr Drug Targets Inflamm Allergy 2004;3:35-42.
7. Rauramaa R, Väisänen SB, Luong LA, Schmidt-Trücksäss A, Penttilä IM, Bouchard C, et al. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 2000;20:2657-62.
8. Taga T, Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997;15:797-819.
9. Derouet D, Rousseau F, Alfonsi F, Froger J, Hermann J, Barbier F, et al. Neuropoietin, A new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor. Proc Natl Acad Sci USA 2004;101:4827-32.
10. Pflanz S, Hibbert L, Mattson J, Rosales R, Vaisberg E, Bazan JF, et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 2004;172:2225-31.
11. Hojo Y, Ikeda U, Takahashi M, Shimada K. Increased levels of monocyte-related cytokines in patients with unstable angina. Atherosclerosis 2002;161:403-8.
12. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol 2001;88:10-5.
13. Loppnow H, Werdan K, Buerke M. Vascular cells contribute to atherosclerosis by cytokineand innate-immunity-related inflammatory mechanisms. Innate Immun 2008;14:63-87.
14. Wara AK, Mitsumata M, Yamane T, Kusumi Y, Yoshida Y. Gene expression in endothelial cells and intimal smooth muscle cells in atherosclerosis-prone or atherosclerosis-resistant regions of the human aorta. J Vasc Res 2008;45:303-13.
15. Deng DX, Spin JM, Tsalenko A, Vailaya A, Ben-Dor A, Yakhini Z, et al. Molecular signatures determining coronary artery and saphenous vein smooth muscle cell phenotypes: distinct responses to stimuli. Arterioscler Thromb Vasc Biol 2006;26:1058-65.
16. Berg KK, Madsen HO, Garred P, Wiseth R, Gunnes S, Videm V. The additive contribution from inflammatory genetic markers on the severity of cardiovascular disease. Scand J Immunol 2009;69:36-42.
17. Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ. The interleukin-6-174C?G promoter polymorphism is associated with risk of coronary artery disease and systolic blood pressure in healthy men. Eur Heart J 2001;22:2243-52.
18. Manginas A, Tsiavou A, Chaidaroglou A, Giamouzis G, Degiannis D, Panagiotakos D, et al. Inflammatory cytokine gene variants in coronary artery disease patients in Greece. Coron Artery Dis 2008;19:575-82.
19. Basso F, Lowe GD, Rumley A, McMahon AD, Humphries SE. Interleukin-6-174G?C polymorphism and risk of coronary heart disease in West of Scotland coronary preventionstudy (WOSCOPS). Arterioscler Thromb Vasc Biol 2002;22:599-604. (Pubitemid 34408740)
20. Pascual M, Nieto A, Matarán L, Balsa A, Pascual-Salcedo D, Martín J. IL-6 promoter polymorphisms in rheumatoid arthritis. Genes Immun 2000;1:338-40.
21. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
22. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;12:836-43. (Pubitemid 30165206)
23. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101:1767-72.
24. Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: Effects of an early invasive or noninvasive strategy. JAMA 2001;286:2107-13.
25. Georges JL, Loukaci V, Poirier O, Evans A, Luc G, Arveiler D, et al. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: The ECTIM study. J Mol Med 2001;79:300-5. (Pubitemid 32646387)
26. Nauck M, Winkelmann BR, Hoffmann MM, Böhm BO, Wieland H, März W. The interleukin-6 G (-174) C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. J Mol Med 2002;80:507-13. (Pubitemid 34983915)
27. Snoussi K, Strosberg AD, Bouaouina N, Ben Ahmed S, Chouchane L. Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma. Eur Cytokine Netw 2005;16:253-60.
28. Sekuri C, Cam FS, Sagcan A, Ercan E, Tengiz I, Alioglu E, et al. No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort. Coron Artery Dis 2007;18:333-7.
29. Manginas A, Tsiavou A, Chaidaroglou A, Giamouzis G, Degiannis D, Panagiotakos D, et al. Inflammatory cytokine gene variants in coronary artery disease patients in Greece. Coron Artery Dis 2008;19:575-82.